Black Diamond Therapeutics
BDTX
BDTX
90 hedge funds and large institutions have $218M invested in Black Diamond Therapeutics in 2024 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 25 increasing their positions, 19 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
6.89% more ownership
Funds ownership: 76.24% → 83.13% (+6.9%)
2% more funds holding
Funds holding: 88 → 90 (+2)
Holders
90
Holding in Top 10
–
Calls
$331K
Puts
$116K
Top Buyers
| 1 | +$18.3M | |
| 2 | +$9.79M | |
| 3 | +$8.56M | |
| 4 |
ABG
Ally Bridge Group
New York
|
+$3.89M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$3.79M |
Top Sellers
| 1 | -$17.9M | |
| 2 | -$4.45M | |
| 3 | -$3.52M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.86M |
| 5 |
Jane Street
New York
|
-$1.27M |